Noveris Health Sciences is trading 10.53% down at CA$0.09, with no clear company-specific catalyst identified for September 14, 2026.
- The latest reported announcement was shareholder approval of all annual-meeting resolutions on September 9, including director elections.
- That announcement does not explain today’s decline.
- Broader markets are only modestly lower, so the move cannot be confidently attributed to market sentiment.